New Results on Treatment of Melanoma - European Cancer Congress (ESMO) 2023

Updates in melanoma at ESMO 2023Подробнее

AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey WeberПодробнее

New Results on Treatment of Early Lung Cancer - European Cancer Congress (ESMO) 2023Подробнее

New Results on Treatment of Supportive Therapies - European Cancer Congress (ESMO) 2023Подробнее

ESMO Immuno-Oncology Congress 2023: Access to all the latest updates in immuno-oncologyПодробнее

ASCO 2021 Highlights on anti LAG3 in advanced melanoma The RELATIVITY 047 studyПодробнее

Highlights from ESMO 2022 in melanomaПодробнее

#ESMO21 Expert Video Report on MelanomaПодробнее

#ESMO23 Melanoma and other skin tumours Track highlights with Chair Teresa AmaralПодробнее

Melanoma | 2022 OneOncology ConferenceПодробнее

Genitourinary cancer highlights at ESMO 2023Подробнее

#ESMO21 Highlights on pembrolizumab in fully resected high-risk stage II melanoma: KEYNOTE-716 studyПодробнее

#ESMO22 Highlights on neoadj. vs adjuvant pembrolizumab in resected stage III-IV melanoma:SWOG S1801Подробнее

#ESMO22 Highlights on TILs versus ipilimumab in patients with advanced melanoma: The phase 3 studyПодробнее

Melanoma & Other Skin Cancers: Essentials for CliniciansПодробнее

#ESMO23 Genitourinary tumours (non-prostate) Track highlights with Chair Michiel van der HeijdenПодробнее

ESMO 2022 HighlightsПодробнее

Expert Commentary: Melanoma, Breast and Gynaecological Cancers at ESMO Congress 2021Подробнее